Patents by Inventor Claudy Mullon

Claudy Mullon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunosuppressive Combination and Its Use in the Treatment or Prophylaxis of Insulin-producing Cell Graft Rejection
    Publication number: 20140093502
    Abstract: A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: Novartis AG
    Inventors: Philip Lake, Claudy Mullon
  • IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
    Publication number: 20110236382
    Abstract: A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.
    Type: Application
    Filed: June 6, 2011
    Publication date: September 29, 2011
    Inventors: Philip LAKE, Claudy Mullon
  • IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
    Publication number: 20080199465
    Abstract: A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.
    Type: Application
    Filed: April 22, 2008
    Publication date: August 21, 2008
    Inventors: Philip Lake, Claudy Mullon
  • Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection
    Publication number: 20060153842
    Abstract: A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.
    Type: Application
    Filed: March 9, 2006
    Publication date: July 13, 2006
    Inventors: Philip Lake, Claudy Mullon
  • Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection
    Publication number: 20030003099
    Abstract: A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.
    Type: Application
    Filed: June 7, 2002
    Publication date: January 2, 2003
    Inventors: Philip Lake, Claudy Mullon
  • Astrocyte apparatus for bioprocessing a circulating fluid
    Patent number: 6300054
    Abstract: The invention relates to a container having astrocytes for use in removing toxins from a biological fluid. The container includes a first port for receiving the biological fluid and a second port through which the biological fluid exits the container. The invention also relates to a method of treating a biological fluid by contacting it with astrocytes.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: October 9, 2001
    Assignee: Circe Biomedical, Inc.
    Inventors: Linda Custer, Claudy Mullon, Roger Butterworth
  • Astrocyte apparatus for bioprocessing a circulating fluid
    Patent number: 6136593
    Abstract: The invention relates to a container having astrocytes for use in removing toxins from a biological fluid. The container includes a first port for receiving the biological fluid and a second port through which the biological fluid exits the container. The invention also relates to a method of treating a biological fluid by contacting it with astrocytes.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: October 24, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Linda Custer, Claudy Mullon, Roger Butterworth